"EO 14398" agilent 9500 ICP-QQQ bundle
Active Purchase Order Awarded
- Contract number
- 75F40126P00309
- Awardee
-
Agilent Technologies Inc. UEI SD9JZ9S7MEA6 Part of Agilent Technologies, Inc.
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $283,395
Award facts
- Opportunity
-
- Inductively coupled plasma triple quadrupole tandem mass spectrometer (ICP-QQQ Tandem MS) including accessories necessary for basic instrument operation (e. g. , chiller), software, and autosampler Solicitation · 75F40126Q133485 · Posted Aug 10, 2026
- Contract value 84% obligated
-
- $283,395.14 Current, with exercised options
- $336,131.78 Potential, with all options
- Completion date 3% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Marshallton, DE 19808, USA
Award details come from SAM.gov/FPDS.
About this award
The Food and Drug Administration awarded a purchase order to Agilent Technologies Inc. for an Agilent 9500 ICP-QQQ analytical instrument bundle valued at $336,131.78 on September 10, 2026.
The procurement is a firm fixed-price commercial item acquisition under FAR Part 12 with full and open competition and no set-aside. Place of performance is Marshallton, Delaware. The order procures a newly manufactured inductively coupled plasma triple quadrupole tandem mass spectrometer system with integrated autosampler, software, delivery, installation, on-site operator training for two users, and a minimum one-year warranty including phone and email technical support. Two optional one-year post-warranty preventive maintenance and repair service agreements are available, each with one annual scheduled on-site preventive maintenance visit and unlimited on-site corrective maintenance within seven business days. The requirement originated in an FDA solicitation posted August 10, 2026, with quotes due August 17, 2026. The ultimate completion date is December 7, 2029.
Quick answers
Who was awarded contract 75F40126P00309?
75F40126P00309 was awarded to Agilent Technologies Inc. by Food and Drug Administration (Department of Health and Human Services) on September 10, 2026.
How much is contract 75F40126P00309 worth?
The government has obligated $283,395 on 75F40126P00309. Its potential value, with all options, is $336,132.
Was contract 75F40126P00309 competed?
The extent of competition for 75F40126P00309 was competed under sap. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award